PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsSeborrheic dermatitis
MeSH D012628 - seborrheic dermatitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D003872:Dermatitis
$
Success rate
D017444:Papulosquamous skin diseases
$
Success rate
D012625:Sebaceous gland diseases
0 Companies
0 Drugs
Success rate
D017443:Eczematous skin diseases
0 Companies
0 Drugs
Success rate
D012628: 
Seborrheic dermatitis
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyCortisone Cortisone  1982-01-01   
AAIPharmaKetoconazole Ketoconazole  1999-07-27   
Alcon ResearchPrednisolone, Sulfacetamide Cetapred  1993-08-06   
Prednisolone, Sulfacetamide Isopto Cetapred  1982-01-01   
AllerganPrednisolone, Sulfacetamide Blephamide  1986-12-03   
Betamethasone Betamethasone  1984-10-10   
Clotrimazole, Betamethasone Clotrimazole Betamethasone  2002-08-02   
Cortisone Cortisone  1982-01-01   
Betamethasone Valnac  1984-10-10   
AlmirallKetoconazole Xolegel  2006-07-28   
AlpharmaBetamethasone Betamethasone  1987-02-03   
American RegentBetamethasone Betamethasone Betamethasone  2009-07-31   
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/3
Phase 2
40%
2/5
Phase 3
71%
12/17
Approved: 8Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Alcon Research
1
2
3
4
5
6
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use